These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8884656)

  • 21. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noradrenergic versus serotonergic antidepressants: predictors of treatment response.
    Schatzberg AF
    J Clin Psychiatry; 1998; 59 Suppl 14():15-8. PubMed ID: 9818626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic imipramine treatment downregulates IR1-imidazoline receptors in rat brainstem.
    Zhu H; Halaris A; Piletz JE
    Life Sci; 1997; 61(19):1973-83. PubMed ID: 9364202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.
    Shen Q; Lal R; Luellen BA; Earnheart JC; Andrews AM; Luscher B
    Biol Psychiatry; 2010 Sep; 68(6):512-20. PubMed ID: 20579975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes.
    Halbreich U; Piletz JE; Carson S; Halaris A; Rojansky N
    Biol Psychiatry; 1993 Nov; 34(10):676-86. PubMed ID: 7904832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3).
    Mooney JJ; Samson JA; Hennen J; Pappalardo K; McHale N; Alpert J; Koutsos M; Schildkraut JJ
    J Psychiatr Res; 2008 Jul; 42(8):605-11. PubMed ID: 17727882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
    Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
    Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.
    Ernsberger P; Haxhiu MA; Graff LM; Collins LA; Dreshaj I; Grove DL; Graves ME; Schäfer SG; Christen MO
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():27-41. PubMed ID: 8068578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imidazoline and alpha(2a)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy.
    Piletz JE; Halbreich U
    Biol Psychiatry; 2000 Nov; 48(9):932-9. PubMed ID: 11074231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M
    Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists.
    Ivanov TR; Feng Y; Wang H; Regunathan S; Reis DJ; Chikkala DN; Gupta P; Jones JC; Piletz JE
    J Psychiatr Res; 1998; 32(2):65-79. PubMed ID: 9694002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
    Rénéric JP; Bouvard M; Stinus L
    Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors.
    Piletz JE; Chikkala DN; Ernsberger P
    J Pharmacol Exp Ther; 1995 Feb; 272(2):581-7. PubMed ID: 7853171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of antidepressant use on social functioning: reboxetine versus fluoxetine.
    Venditti LN; Arcelus A; Birnbaum H; Greenberg P; Barr CE; Rowland C; Williamson T
    Int Clin Psychopharmacol; 2000 Sep; 15(5):279-89. PubMed ID: 10993130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet imidazoline receptors and regulatory G proteins in patients with major depression.
    García-Sevilla JA; Escribá PV; Busquets X; Walzer C; Guimón J
    Neuroreport; 1996 Dec; 8(1):169-72. PubMed ID: 9051774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Norepinephrine involvement in antidepressant action.
    Frazer A
    J Clin Psychiatry; 2000; 61 Suppl 10():25-30. PubMed ID: 10910014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet alpha 2-adrenergic receptors in depressed patients and healthy volunteers: the effects of desipramine.
    Werstiuk ES; Auffarth SE; Coote M; Gupta RN; Steiner M
    Pharmacopsychiatry; 1992 Jul; 25(4):199-206. PubMed ID: 1326772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.